Prostate cancer is the most common cancer among men in the Western world. Despite its prevalence, recent advances in diagnosis and treatment have transformed how it’s managed—offering greater precision, less patient discomfort, and significantly improved quality of life.
Early Detection Remains the Key
One of the defining features of prostate cancer is that it typically causes no symptoms in its earliest stages. For this reason, routine screening is critical. The PSA blood test remains the first-line tool for detecting potential issues—but it’s not sufficient on its own. Regular visits to a urologist and digital rectal examination (DRE) continue to play an essential role. Some aggressive forms of prostate cancer may not elevate PSA levels at all. In such cases, clinical examination can reveal abnormalities that would otherwise go undetected.
A New Era in Prostate Biopsy
Following laboratory and clinical evaluation, multiparametric MRI has become pivotal in precisely identifying suspicious areas within the prostate. However, the biggest shift lies in biopsy technique. Traditional transrectal biopsy has largely been replaced by MRI–ultrasound fusion biopsy—a minimally invasive procedure performed under sedation. Using specialized software, MRI images are fused in real time with ultrasound guidance, enabling the urologist to target suspicious lesions with exceptional accuracy. This method is safer—significantly reducing infection risk—and far more diagnostically accurate than older approaches. As a result, repeat biopsies are less often needed, and the chances of timely, correct diagnosis are substantially increased.
Robotic Surgery: Greater Precision, Better Quality of Life
A prostate cancer diagnosis still triggers anxiety—not only because of the word “cancer,” but also due to concerns about treatment side effects, especially urinary incontinence and erectile dysfunction. These fears largely stem from experiences with older surgical techniques. Today, robotic surgery has fundamentally changed the landscape.
Robotic-assisted radical prostatectomy is now the internationally established standard for localized disease. It delivers high precision, minimal invasiveness, and markedly improved functional outcomes. Modern robotic systems provide magnified, high-definition 3D visualization and enhanced dexterity, allowing surgeons to carefully preserve critical anatomical structures tied to continence and sexual function. Emerging refinements—such as Retzius-sparing robotic prostatectomy—further reduce incontinence rates. In many cases, patients regain full urinary control shortly after surgery.